Press Releases
January 13, 2026
Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Investments in Colorless Polyimide Films Market for 2026
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Cloud API Market Trends, Investment Opportunities, and Growth Analysis Through 2033 Featuring Amazon Web Services, Inc.
Neutral
EIN Presswire
January 12, 2026
Village Farms International Advances New Product Innovation in the Dutch Market
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Fat Replacers Market Size to Exceed USD 5.40 Billion by 2035 | Towards FnB
Indeterminate
GlobeNewswire, Inc.
January 13, 2026
TomTom launches Area Analytics for more precise traffic insights at scale
Indeterminate
GlobeNewswire, Inc.
January 13, 2026
argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
TRANSCRIPT: Governor Hobbs 2026 State of the State Address
Gov't Institution
Governor of Arizona
Owner: American Government
January 9, 2026
Wolters Kluwer appoints Maria Montenegro as CEO of Corporate Performance & ESG division
Indeterminate
GlobeNewswire, Inc.
January 9, 2026
Deep-Sea Mining Market Expands as Governments and Industries Race to Secure Critical Mineral Supply Chains
Indeterminate
GlobeNewswire, Inc.
January 9, 2026
Trends and Investments in Fiberboard Packaging Market 2025-35
Indeterminate
GlobeNewswire, Inc.
January 6, 2026
Netherlands supports Greenland, Denmark’s right to decide their future
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
January 8, 2026
The Vita Coco Company Appoints Shelley Broader to Board of Directors
Indeterminate
GlobeNewswire, Inc.
January 8, 2026
SailSupply Announces Launch of New Website for Dutch Watersports Enthusiasts and Sailors
Indeterminate
The News Front
January 8, 2026
Personalized Nutrition Market to Witness Remarkable Growth With DSM-Firmenich, BASF SE, Amway Corp
Neutral
EIN Presswire
January 8, 2026
VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization
Indeterminate
GlobeNewswire, Inc.